Sangamo Announces ASGCT 2024

Sangamo Therapeutics Announces Participation at 2021 Wedbush PacGrow Healthcare Conference

BRISBANE, Calif. --(BUSINESS WIRE)--Aug. 9, 2021-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will participate in a fireside chat at the 2021 Wedbush PacGrow Healthcare Conference on Wednesday, August 11 th at 2:55pm Eastern Time .